New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareNoopept vs Cardiogen

Noopept vs Cardiogen

Side-by-side comparison of key properties, dosing, and research.

Cognitive Enhancement
Noopept
Anti-Aging & Longevity
Cardiogen
Summary
Noopept is a potent dipeptide-derived nootropic from Russia, structurally related to piracetam but estimated to be 1,000 times more potent by mass. It enhances memory consolidation, learning, and recall while providing neuroprotection via BDNF and NGF upregulation.
Cardiogen is a tetrapeptide bioregulator (Ala-Glu-Asp-Arg) developed by Professor Vladimir Khavinson. It is a tissue-specific bioregulator for the heart and myocardium, designed to normalize cardiomyocyte function and support cardiac tissue regeneration. Research has demonstrated cardioprotective effects, improved cardiac rhythm, and benefits in recovery from ischemic injury.
Half-Life
~5–10 minutes but metabolite (CPG) effects last hours
Short (minutes); gene-regulatory effects persist longer
Admin Route
Oral, Sublingual, Intranasal
SubQ, Oral
Research
Typical Dose
10–30 mg
10 mg per day
Frequency
1–2x daily
Daily for 10–30 days
Key Benefits
  • Enhances memory formation and recall
  • Improves learning speed and cognitive processing
  • Neuroprotective via BDNF/NGF upregulation
  • Anxiolytic at low-to-moderate doses
  • Improves verbal fluency and information processing
  • Antioxidant (reduces oxidative damage in neurons)
  • May improve cognitive symptoms of mild cognitive impairment
  • Cardioprotective effects on myocardial tissue
  • Normalization of cardiomyocyte protein synthesis
  • May improve cardiac rhythm and conduction
  • Support for recovery from ischemic cardiac events
  • Anti-aging effects on heart tissue
  • Potential reduction in cardiac fibrosis
  • Often combined with Epithalon for comprehensive cardiovascular longevity support
Side Effects
  • Headaches (choline depletion — pair with choline source)
  • Irritability or anxiety at high doses
  • Overstimulation
  • Rare: brain fog with chronic use
  • +1 more
  • Generally well tolerated in available research
  • Mild injection site reactions
  • No significant adverse cardiovascular events reported at standard doses
Stacks With